Verde Science has assembled a highly experienced, well-funded team that will deploy state-of-the-art research technology and the superior growing methodology of aeroponics to enter and take a meaningful market share. The company is launching its THC Pharmaceutical Development Program by executing a comprehensive research program which involves developing custom formulations preparing protocols for clinical trials which will initially be conducted through its partnership alliance with a pharmaceutical company in Mumbai, India.
Verde Science plans to develop specific, custom formulations and novel delivery mechanisms for cannabinoid and THC based drugs for a variety of ailments including chronic pain, inflammation, migraines, seizures related to epilepsy, nausea associated with cancer treatment, and numerous others. The company then plans to then conduct clinical trials in Canada after it obtains its Canadian R&D license.
With consistent, highly efficient production of clean product with no pesticides grown in environmentally friendly surroundings using recycled water, and custom cannabinoid formulations with novel delivery mechanisms, Canada will soon be introduced to the “Tesla” of medical marijuana.
Marijuana Grown with Aeroponics
Aeroponics is the process of growing plants in an air or mist environment without the use of soil or an aggregate medium (known as geoponics). The word “aeroponic” is derived from the Greek meanings of aero- (air) and ponos (labor). Aeroponic culture differs from conventional hydroponics, aquaponics, and in-vitro (plant tissue culture) growing. Unlike hydroponics, which uses a liquid nutrient solution as a growing medium and essential minerals to sustain plant growth; or aquaponics, which uses water and fish waste, aeroponics is conducted without a growing medium. Because water is used in aeroponics to transmit nutrients, it is sometimes considered a type of hydroponics.